Two-dose-level confirmatory study of the pharmacokinetics and tolerability of everolimus in Chinese patients with advanced solid tumors

BACKGROUND: This phase I, randomized, multicenter, open-label study investigated the pharmacokinetics, safety, and efficacy of the oral mammalian target of rapamycin inhibitor everolimus in Chinese patients with advanced solid tumors. METHODS: A total of 24 patients with advanced breast cancer (n =...

Descripción completa

Detalles Bibliográficos
Autores principales: Xu, BingHe, Wu, YiLong, Shen, Lin, Ye, DingWei, Jappe, Annette, Cherfi, Azzeddine, Wang, Hui, Yuan, RuiRong
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2011
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3032760/
https://www.ncbi.nlm.nih.gov/pubmed/21232120
http://dx.doi.org/10.1186/1756-8722-4-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3032760/
https://www.ncbi.nlm.nih.gov/pubmed/21232120
http://dx.doi.org/10.1186/1756-8722-4-3

Ejemplares similares